Queensland life sciences spin-out Vaxxas secures A$25m ($20m) for needleless injection technologies.

Tech giant IBM partners Witswatersrand on joint research and incubator hub in Johannesburg.

BP allies with Masdar Institute of Science and Technology on energy accelerator.

Following a cancelled deal with pharmaceutical company Roche, the Ofer-backed pharmaceutical company has raised the first tranche of a planned $56.3m series E round.

New Zealand-based commercialisation firm Powerhouse Ventures considers IPO.

Cirrus Materials Science, a spin-out developing surface coatings for use in manufacturing, launches out of Auckland University.

Tel Aviv's TTO Ramot closes its Technology Innovation Momentum Fund with $23.5m in the tank.

Two Auckland spin-outs and Fraunhofer Institute collaborate to bring an exoskeleton arm brace to market within three years.